Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Proteomics analysis of human breast milk to assess breast cancer risk.

Aslebagh R, Channaveerappa D, Arcaro KF, Darie CC.

Electrophoresis. 2018 Feb;39(4):653-665. doi: 10.1002/elps.201700123.

PMID:
29193311
2.

Selective Adhesive Cell Capture without Molecular Specificity: New Surfaces Exploiting Nanoscopic Polycationic Features as Discrete Adhesive Units.

Kalasin S, Browne EP, Arcaro KF, Santore MM.

RSC Adv. 2017;7:13416-13425. doi: 10.1039/C7RA01217A. Epub 2017 Feb 28.

PMID:
28989702
3.

White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).

Sturgeon SR, Pilsner JR, Arcaro KF, Ikuma K, Wu H, Kim SM, Chopra-Tandon N, Karpf AR, Ziegler RG, Schairer C, Balasubramanian R, Reckhow DA.

Breast Cancer Res. 2017 Aug 18;19(1):94. doi: 10.1186/s13058-017-0886-6.

4.

Tools to minimize interlaboratory variability in vitellogenin gene expression monitoring programs.

Jastrow A, Gordon DA, Auger KM, Punska EC, Arcaro KF, Keteles K, Winkelman D, Lattier D, Biales A, Lazorchak JM.

Environ Toxicol Chem. 2017 Nov;36(11):3102-3107. doi: 10.1002/etc.3885. Epub 2017 Aug 14.

PMID:
28631833
5.

Relationships between Global DNA Methylation in Circulating White Blood Cells and Breast Cancer Risk Factors.

Chopra-Tandon N, Wu H, Arcaro KF, Sturgeon SR.

J Cancer Epidemiol. 2017;2017:2705860. doi: 10.1155/2017/2705860. Epub 2017 Apr 6. Review.

6.

Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations.

Murphy J, Sherman ME, Browne EP, Caballero AI, Punska EC, Pfeiffer RM, Yang HP, Lee M, Yang H, Gierach GL, Arcaro KF.

Breast Cancer Res Treat. 2016 May;157(1):13-22. doi: 10.1007/s10549-016-3796-x. Epub 2016 Apr 23. Review.

7.

ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors.

Fitzgerald LM, Browne EP, Christie KD, Punska EC, Simmons LO, Williams KE, Pentecost BT, M Jawale R, Otis CN, Arcaro KF.

Cancer Cell Int. 2016 Feb 16;16:8. doi: 10.1186/s12935-016-0282-9. eCollection 2016.

8.

Depression, Antidepressant Use, and Postmenopausal Breast Cancer Risk.

Brown SB, Hankinson SE, Arcaro KF, Qian J, Reeves KW.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):158-64. doi: 10.1158/1055-9965.EPI-15-1063. Epub 2015 Nov 17.

9.

Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors.

Chen X, Liu L, Mims J, Punska EC, Williams KE, Zhao W, Arcaro KF, Tsang AW, Zhou X, Furdui CM.

Epigenetics. 2015;10(6):545-61. doi: 10.1080/15592294.2015.1048953.

10.

Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis.

Yang HP, Schneider SS, Chisholm CM, Browne EP, Mahmood S, Gierach GL, Lenington S, Anderton DL, Sherman ME, Arcaro KF.

Cancer Causes Control. 2015 Mar;26(3):345-54. doi: 10.1007/s10552-014-0498-8. Epub 2015 Jan 21.

11.

Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II.

Brown SB, Hankinson SE, Eliassen AH, Reeves KW, Qian J, Arcaro KF, Wegrzyn LR, Willett WC, Schernhammer ES.

Am J Epidemiol. 2015 Feb 1;181(3):155-62. doi: 10.1093/aje/kwu261. Epub 2015 Jan 13.

12.

Activation of epidermal growth factor receptor is required for Chlamydia trachomatis development.

Patel AL, Chen X, Wood ST, Stuart ES, Arcaro KF, Molina DP, Petrovic S, Furdui CM, Tsang AW.

BMC Microbiol. 2014 Dec 4;14:277. doi: 10.1186/s12866-014-0277-4.

13.

Promoter methylation in epithelial-enriched and epithelial-depleted cell populations isolated from breast milk.

Browne EP, Dinc SE, Punska EC, Agus S, Vitrinel A, Erdag GC, Anderton DL, Arcaro KF, Yilmaz B.

J Hum Lact. 2014 Nov;30(4):450-7. doi: 10.1177/0890334414548224. Epub 2014 Aug 27.

PMID:
25164041
14.

Human Mammary Tumor Virus (HMTV) sequences in human milk.

Nartey T, Moran H, Marin T, Arcaro KF, Anderton DL, Etkind P, Holland JF, Melana SM, Pogo BG.

Infect Agent Cancer. 2014 Jun 17;9:20. doi: 10.1186/1750-9378-9-20. eCollection 2014.

15.

Using breast milk to assess breast cancer risk: the role of mass spectrometry-based proteomics.

Schneider SS, Aslebagh R, Ngounou Wetie AG, Sturgeon SR, Darie CC, Arcaro KF.

Adv Exp Med Biol. 2014;806:399-408. doi: 10.1007/978-3-319-06068-2_19. Review.

PMID:
24952194
16.

DNA methylation in paired breast epithelial and white blood cells from women undergoing reduction mammoplasty.

Sturgeon SR, Arcaro KF, Johnson MA, Balasubramanian R, Zorn M, Jerry DJ, Schneider SS.

Anticancer Res. 2014 Jun;34(6):2985-90.

PMID:
24922663
17.

Determination of free Bisphenol A (BPA) concentrations in breast milk of U.S. women using a sensitive LC/MS/MS method.

Zimmers SM, Browne EP, O'Keefe PW, Anderton DL, Kramer L, Reckhow DA, Arcaro KF.

Chemosphere. 2014 Jun;104:237-43. doi: 10.1016/j.chemosphere.2013.12.085. Epub 2014 Feb 4.

PMID:
24507723
18.

SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer.

Fagan-Solis KD, Pentecost BT, Gozgit JM, Bentley BA, Marconi SM, Otis CN, Anderton DL, Schneider SS, Arcaro KF.

J Cell Physiol. 2014 Sep;229(9):1160-9. doi: 10.1002/jcp.24545.

PMID:
24443386
19.

High-density array analysis of DNA methylation in Tamoxifen-resistant breast cancer cell lines.

Williams KE, Anderton DL, Lee MP, Pentecost BT, Arcaro KF.

Epigenetics. 2014 Feb;9(2):297-307. doi: 10.4161/epi.27111. Epub 2013 Nov 13.

20.

Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop.

Faupel-Badger JM, Arcaro KF, Balkam JJ, Eliassen AH, Hassiotou F, Lebrilla CB, Michels KB, Palmer JR, Schedin P, Stuebe AM, Watson CJ, Sherman ME.

J Natl Cancer Inst. 2013 Feb 6;105(3):166-74. doi: 10.1093/jnci/djs505. Epub 2012 Dec 21. Review.

21.

The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line.

Fagan-Solis KD, Schneider SS, Pentecost BT, Bentley BA, Otis CN, Gierthy JF, Arcaro KF.

J Cell Biochem. 2013 Jun;114(6):1385-94. doi: 10.1002/jcb.24480.

PMID:
23255405
22.

Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls.

Sturgeon SR, Balasubramanian R, Schairer C, Muss HB, Ziegler RG, Arcaro KF.

Epigenetics. 2012 Nov;7(11):1258-67. doi: 10.4161/epi.22220. Epub 2012 Sep 17.

23.

Differential expression of cancer-related proteins in paired breast milk samples from women with breast cancer.

Arcaro KF, Browne EP, Qin W, Zhang K, Anderton DL, Sauter ER.

J Hum Lact. 2012 Nov;28(4):543-6. doi: 10.1177/0890334412453205. Epub 2012 Aug 20.

PMID:
22914689
24.

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers.

Turk CM, Fagan-Solis KD, Williams KE, Gozgit JM, Smith-Schneider S, Marconi SA, Otis CN, Crisi GM, Anderton DL, Kilimann MW, Arcaro KF.

Cancer Cell Int. 2012 May 10;12(1):17. doi: 10.1186/1475-2867-12-17.

25.

Differential expression of cancer associated proteins in breast milk based on age at first full term pregnancy.

Qin W, Zhang K, Kliethermes B, Ruhlen RL, Browne EP, Arcaro KF, Sauter ER.

BMC Cancer. 2012 Mar 21;12:100. doi: 10.1186/1471-2407-12-100.

26.

Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy.

Browne EP, Punska EC, Lenington S, Otis CN, Anderton DL, Arcaro KF.

Epigenetics. 2011 Dec;6(12):1425-35. doi: 10.4161/epi.6.12.18280.

PMID:
22139572
27.

Surface properties dictate uptake, distribution, excretion, and toxicity of nanoparticles in fish.

Zhu ZJ, Carboni R, Quercio MJ Jr, Yan B, Miranda OR, Anderton DL, Arcaro KF, Rotello VM, Vachet RW.

Small. 2010 Oct 18;6(20):2261-5. doi: 10.1002/smll.201000989. No abstract available.

28.

Effects of exposure water volume, depuration time, and feeding status on vitellogenin mRNA induction in male medaka (Oryzias latipes) exposed to 17 β-estradiol.

Moffatt LT, May CL, Studer KE, Reckhow DA, Arcaro KF.

Ecotoxicol Environ Saf. 2010 Nov;73(8):1835-41. doi: 10.1016/j.ecoenv.2010.08.024. Epub 2010 Sep 9.

PMID:
20825989
29.

The role of surface functionality on acute cytotoxicity, ROS generation and DNA damage by cationic gold nanoparticles.

Chompoosor A, Saha K, Ghosh PS, Macarthy DJ, Miranda OR, Zhu ZJ, Arcaro KF, Rotello VM.

Small. 2010 Oct 18;6(20):2246-9. doi: 10.1002/smll.201000463. No abstract available.

30.

Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women.

Wong CM, Anderton DL, Smith-Schneider S, Wing MA, Greven MC, Arcaro KF.

Epigenetics. 2010 Oct 1;5(7):645-55. doi: 10.4161/epi.5.7.12961. Epub 2010 Oct 1.

31.

Potential of using breast milk as a tool to study breast cancer and breast cancer risk.

Arcaro KF, Anderton DL.

Future Oncol. 2008 Oct;4(5):595-7. doi: 10.2217/14796694.4.5.595. No abstract available.

32.

Perfluorinated compounds in human milk from Massachusetts, U.S.A.

Tao L, Kannan K, Wong CM, Arcaro KF, Butenhoff JL.

Environ Sci Technol. 2008 Apr 15;42(8):3096-101.

PMID:
18497172
33.

PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas.

Gozgit JM, Pentecost BT, Marconi SA, Ricketts-Loriaux RS, Otis CN, Arcaro KF.

Br J Cancer. 2007 Sep 17;97(6):809-17. Epub 2007 Aug 28.

34.

Synthetic musk fragrances in human milk from the United States.

Reiner JL, Wong CM, Arcaro KF, Kannan K.

Environ Sci Technol. 2007 Jun 1;41(11):3815-20.

PMID:
17612154
35.

Effects of polycyclic aromatic hydrocarbon-containing oil mixtures on generation of reactive oxygen species and cell viability in MCF-7 breast cancer cells.

Yilmaz B, Ssempebwa J, Mackerer CR, Arcaro KF, Carpenter DO.

J Toxicol Environ Health A. 2007 Jul;70(13):1108-15.

PMID:
17558805
36.

Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer.

Gozgit JM, Pentecost BT, Marconi SA, Otis CN, Wu C, Arcaro KF.

Mol Cancer Res. 2006 Dec;4(12):905-13.

37.

Differential action of polycyclic aromatic hydrocarbons on endogenous estrogen-responsive genes and on a transfected estrogen-responsive reporter in MCF-7 cells.

Gozgit JM, Nestor KM, Fasco MJ, Pentecost BT, Arcaro KF.

Toxicol Appl Pharmacol. 2004 Apr 1;196(1):58-67.

PMID:
15050408
38.

Beta-galactosidase and alpha-mannosidase inhibit formation of multicellular nodules in breast cancer cell cultures.

Arcaro KF, Wang J, Otis CN, Zuckerman BM.

Anticancer Res. 2004 Jan-Feb;24(1):139-44.

39.

Assessing modulation of estrogenic activity of environmental and pharmaceutical compounds using MCF-7 focus assay.

Arcaro KF, Gierthy JF.

Methods Mol Biol. 2001;176:341-51. Review. No abstract available.

PMID:
11554334
40.

Antiestrogenicity of clarified slurry oil and two crude oils in a human breast-cancer cell assay.

Arcaro KF, Gierthy JF, Mackerer CR.

J Toxicol Environ Health A. 2001 Apr 6;62(7):505-21.

PMID:
11289701
41.

Expression of an estrogen receptor alpha variant protein in cell lines and tumors.

Fasco MJ, Keyomarsi K, Arcaro KF, Gierthy JF.

Mol Cell Endocrinol. 2000 Aug 30;166(2):156-69.

PMID:
11203301
42.

Erratum to "Expression of an estrogen receptor alpha variant protein in cell lines and tumors".

Fasco MJ, Keyomarsi K, Arcaro KF, Gierthy JF.

Mol Cell Endocrinol. 2000 Aug 30;166(2):155-69. No abstract available.

PMID:
10996434
43.

Expression of an estrogen receptor alpha variant protein in cell lines and tumors.

Fasco MJ, Keyomarsi K, Arcaro KF, Gierthy JF.

Mol Cell Endocrinol. 2000 Apr 25;162(1-2):167-80. Corrected and republished in: Mol Cell Endocrinol. 2000 Aug 30;166(2):156-69.

PMID:
10854710
44.

Toxaphene is antiestrogenic in a human breast-cancer cell assay.

Arcaro KF, Yang Y, Vakharia DD, Gierthy JF.

J Toxicol Environ Health A. 2000 Feb 11;59(3):197-210.

PMID:
10667634
45.

Benzo[k]fluoranthene enhancement and suppression of 17beta-estradiol catabolism in MCF-7 breast cancer cells.

Arcaro KF, Yang Y, Gierthy JF.

J Toxicol Environ Health A. 1999 Dec 10;58(7):413-26.

PMID:
10616190
46.
47.

Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells.

Arcaro KF, O'Keefe PW, Yang Y, Clayton W, Gierthy JF.

Toxicology. 1999 Apr 15;133(2-3):115-27.

PMID:
10378478
48.

2,2',6,6'-Tetrachlorobiphenyl is estrogenic in vitro and in vivo.

Arcaro KF, Yi L, Seegal RF, Vakharia DD, Yang Y, Spink DC, Brosch K, Gierthy JF.

J Cell Biochem. 1999 Jan 1;72(1):94-102.

PMID:
10025670
49.

Human health and chemical mixtures: an overview.

Carpenter DO, Arcaro KF, Bush B, Niemi WD, Pang S, Vakharia DD.

Environ Health Perspect. 1998 Dec;106 Suppl 6:1263-70. Review.

50.

Lack of synergy by mixtures of weakly estrogenic hydroxylated polychlorinated biphenyls and pesticides.

Arcaro KF, Vakharia DD, Yang Y, Gierthy JF.

Environ Health Perspect. 1998 Aug;106 Suppl 4:1041-6.

Supplemental Content

Loading ...
Support Center